ENTRY EC 5.99.1.3
NAME DNA topoisomerase (ATP-hydrolysing)
Type II DNA topoisomerase
DNA-gyrase
CLASS Isomerases
Other isomerases
SYSNAME DNA topoisomerase (ATP-hydrolysing)
REACTION ATP-dependent breakage, passage and rejoining of double-stranded
DNA
SUBSTRATE Double-stranded DNA
ATP
PRODUCT Double-stranded DNA
ADP
Orthophosphate
INHIBITOR Novobiocin
GRI22222X
Coumermycin A1
Nalidixic acid
Ciprofloxacin
COMMENT The enzyme can introduce negative superhelical turns into
double-stranded circular DNA. One unit has nicking-closing
activity, and another catalyses super-twisting and hydrolysis of
ATP (cf. EC 5.99.1.2 DNA topoisomerase).
Inhibited by two groups of antibiotics, the coumarins and the
quinolones. The coumarins (e.g. novobiocin, coumermycin A1)
act at the B subunit (Proc.Nat.Acad.Sci.U.S.A. 1978, 75,
4838-4842). The quinolones (e.g. nalidixic acid, ciprofloxacin)
act on the A subunit. GRI22222X and cyclothialidine are a new
class of inhibitor (Antimicrob.Agents Chemother. 1994, 37,
2656-2661).
DISEASE MIM: 126430 Topoisomerase (DNA) II, alpha (170kD)
MIM: 126431 Topoisomerase (DNA) II, beta (180kD)
MIM: 208900 Ataxia-telangiectasia mutated (includes
complementation groups A, C,; Ataxia-telangiectasia
(3); T-cell prolymphocytic leukemia, sporadic (3);
B-cell non-Hodgkin lymphoma, sporadic (3)
MOTIF PS: PS00177 [LIVMA]-x-E-G-[DN]-S-A-x-[STAG]
GENES MJA: MJ1512
ECO: b2231(gyrA) b3699(gyrB)
HIN: HI0567(gyrB) HI1264(gyrA)
HPY: HP0501(gyrB) HP0701(gyrA)
BSU: gyrA(nalA) gyrB(novA)
MGE: MG003(gyrB) MG004(gyrA)
MPN: K05_orf650(gyrB) K05_orf839o(gyrA)
SYN: sll1941(gyrA) sll2005(gyrB) slr0417(gyrA)
SCE: YNL088W(TOP2)
HSA: TOP2B(Hs.75248)
DBLINKS University of Geneva ENZYME DATA BANK: 5.99.1.3
WIT (What Is There) Metabolic Reconstruction: 5.99.1.3
///
DBGET integrated database retrieval system,
GenomeNet